Novel Applications of Biomarkers and Personalized Medicine in Cystic Fibrosis

As routine care in cystic fibrosis (CF) becomes increasingly personalized, new opportunities to further focus care on the individual have emerged. These opportunities are increasingly filled through research in tools aiding drug selection, drug monitoring and titration, disease-relevant biomarkers,...

Full description

Saved in:
Bibliographic Details
Published inClinics in chest medicine Vol. 43; no. 4; p. 617
Main Authors Guimbellot, Jennifer S, Nichols, David P, Brewington, John J
Format Journal Article
LanguageEnglish
Published United States 01.12.2022
Subjects
Biomarkers
Cystic Fibrosis - drug therapy
Cystic Fibrosis Transmembrane Conductance Regulator - genetics
Cystic Fibrosis Transmembrane Conductance Regulator - therapeutic use
Humans
Mutation
Precision Medicine
Cystic fibrosis
CFTR modulator
Personalized medicine
CFTR
Online AccessGet more information

Cover

More Information
Summary:As routine care in cystic fibrosis (CF) becomes increasingly personalized, new opportunities to further focus care on the individual have emerged. These opportunities are increasingly filled through research in tools aiding drug selection, drug monitoring and titration, disease-relevant biomarkers, and evaluation of therapeutic benefits. Herein, we will discuss such research tools presently being translated into the clinic to improve the personalization of care in CF.
ISSN:1557-8216
DOI:10.1016/j.ccm.2022.06.005